EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Aquaporin 4 and the endocannabinoid system: a potential therapeutic target in brain injury

Ari Misael Martínez-Torres, Julio Morán

Experimental Brain Research · 2024

DOI: 10.1007/s00221-024-06896-7 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Experimental Brain Research, 2024. Verfasst von Ari Misael Martínez-Torres und 1 weiteren Autor:innen. Beteiligte Einrichtung: División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Coyoacán, Apartado Postal 70-253, 04510, Ciudad …. Hauptthemen laut MEDLINE: Endocannabinoids, Aquaporin 4, Brain Edema, Brain Injuries. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brain edema is a critical complication arising from stroke and traumatic brain injury (TBI) with an important impact on patient recovery and can lead to long-term consequences. Therapeutic options to reduce edema progression are limited with variable patient outcomes. Aquaporin 4 (AQP4) is a water channel that allows bidirectional water diffusion across the astrocyte membrane and participates in the distinct phases of cerebral edema. The absence or inhibition of this channel has been demonstrated to ameliorate edema and brain damage. The endocannabinoid system (ECS) is a neuromodulator system with a wide expression in the brain and its activation has shown neuroprotective properties in diverse models of neuronal damage. This review describes and discusses the major features of ECS and AQP4 and their role during brain damage, observing that ECS stimulation reduces edema and injury size in diverse models of brain damage, however, the relationship between AQP4 expression and dynamics and ECS activation remains unclear. The research on these topics holds promising therapeutic implications for the treatment of brain edema following stroke and TBI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndocannabinoidsAquaporin 4Brain EdemaBrain InjuriesHumansAnimalsBrain Injuries, Traumatic

Stichwörter der Autor:innen

AQP4Brain injuryCannabinoidsEdemaNeuroprotection

Substanzen

EndocannabinoidsAquaporin 4

Autor:innen und Institutionen

  • División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Coyoacán, Apartado Postal 70-253, 04510, Ciudad de Mexico, México.
  • División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Coyoacán, Apartado Postal 70-253, 04510, Ciudad de Mexico, México. jmoran@ifc.unam.mx.

Förderung

  • Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México

Zitieren

APA

Martínez-Torres, A. M., & Morán, J. (2024). Aquaporin 4 and the endocannabinoid system: a potential therapeutic target in brain injury. Experimental Brain Research. https://doi.org/10.1007/s00221-024-06896-7

Vancouver

Martínez-Torres AM, Morán J. Aquaporin 4 and the endocannabinoid system: a potential therapeutic target in brain injury. Experimental Brain Research. 2024. doi:10.1007/s00221-024-06896-7

BibTeX
@article{MartnezTorres2024,
  author = {Martínez-Torres, Ari Misael and Morán, Julio},
  title = {Aquaporin 4 and the endocannabinoid system: a potential therapeutic target in brain injury},
  journal = {Experimental Brain Research},
  year = {2024},
  doi = {10.1007/s00221-024-06896-7}
}
Kostenlos starten →